logo
Lupita Nyong'o Revealed She Has Painful Uterine Fibroids. Here's What That Means.

Lupita Nyong'o Revealed She Has Painful Uterine Fibroids. Here's What That Means.

Yahoo2 days ago
Actress Luptia Nyong'o shared on Instagram that the same year she won an Academy Award for her role in '12 Years A Slave' (2014)she was also diagnosed with chronic uterine fibroids, a common yet understudied medical issue in women — and particularly, Black women.
In the Instagram post, Nyong'o said she had 30 fibroids removed only to be told there is nothing she can do to keep them from coming back.
Her post is part of a campaign to raise awareness for uterine fibroids, support research funding and push forward Congressional bills. Nyong'o shared this news as a way to break the 'silent suffering' that's forced on women.
And while Nyong'o is a well-known person dealing with the often-painful condition, millions of other women deal with it, too. Both in silence and at endless doctor's appointments.
For instance, Tanika Gray Valbrun started experiencing extremely heavy periods early in her teen years.
'I was that girl who always had to carry pads with her, felt like I was always on my period, had to wear two panties and biker shorts, always had an extra bag with me,' she told HuffPost.
In addition to the heavy bleeding, Valbrun also experienced painful periods, her abdomen protruded and she felt a constant need to use the bathroom.
It wasn't until she was about 25 that she received a diagnosis: uterine fibroids. Many doctors appointments and treatments followed, and though she is still on this medical journey, the source of her issues is no longer a mystery.
Although fibroids are quite common, they remain relatively unknown or misunderstood for many. 'Uterine fibroids are benign tumors that grow from smooth muscle cells, so they're often found in the uterus,' said Dr. Sawsan As-Sanie, an associate professor in the department of obstetrics and gynecology at the University of Michigan Medical School. 'They can be in the lining of the uterus, the wall of the uterus or on the surface.'
Also called leiomyomas or myomas, fibroids vary in shape, size and number. Some grow slowly over many years while others might remain the same size for a long time and then start to grow rapidly.
'Looking back, I think about how many times I had accommodated my life for fibroids,' Valbrun said. 'I was always strategizing what to bring or how to dress because I would be bleeding. I never wore white clothing, even though I love whites and light colors.'
Below, experts break down the facts and misconceptions around uterine fibroids.
Who is most likely to have fibroids?
'Fibroids are highly prevalent, and they become more common as patients get older,' As-Sanie noted.
The National Institutes of Health estimates that up to 70% of white women and 80% to 90% of Black women will develop fibroids by the age of 50.
'Really, anyone with a uterus can experience uterine fibroids, but they disproportionately impact Black women at a higher rate,' Valbrun said. 'Black women are more likely to experience them, and their fibroids are more likely to occur when they're younger, grow more quickly and cause more symptoms.'
Age is a big risk factor with fibroids, as their prevalence increases as patients grow older and then declines in post-menopausal women. Although fibroids are most common in women ages 30 to 40 and in Black women, As-Sanie said that she sees them in patients of all ages, races and ethnicities.
'Mine started in my teenage years, so it's not just an issue for women in their childbearing years,' Valbrun added. 'And even though race is a risk factor, it's not just a Black woman's disease ― just like endometriosis is not just a white woman's thing.'
There are genetic factors as well. A family history of fibroids is associated with a three times greater risk of developing fibroids compared with women without that history, As-Sanie explained. She noted that obesity and nulliparous (the medical term for having never given birth) can also be factors.
What are the symptoms?
Despite their prevalence, fibroids don't cause symptoms in the majority of people who have them.
'Only about a quarter of women who have uterine fibroids have symptoms that are bothersome enough that they end up needing intervention,' As-Sanie said.
The most common symptoms are related to menstruation, such as heavy bleeding and pelvic pain.
'Any amount of bleeding that interferes with quality of life deserves an evaluation,' As-Sanie noted. 'We tell patients if they're soaking through a pad or tampon more frequently than every one to two hours, that should warrant evaluation. That amount can lead to anemia, low blood counts.'
Valbrun said that she's had to have at least five blood transfusions over the years to address her severe anemia.
'I was always craving ice and soap, so much that I would be constantly trying to smell them,' she recalled. 'My doctor told me it's called pica, and it's what happens when your body is deficient in iron.'
In addition to menstrual pain, fibroids can also cause pain during sex and at random times. As Valbrun reported, they may lead to swelling in the uterus and abdomen as well.
'Patients can also have what we call 'bulk symptoms' ― pressure from fibroids if they get large enough, feelings of bloating, urinary frequency and urgency, and even constipation or other bowel issues,' As-Sanie said. 'Fibroids are also associated with pregnancy-related complications like miscarriage and infertility.'
How are fibroids diagnosed?
'In terms of diagnosis, fibroids are generally diagnosed or at least suspected during a pelvic exam,' As-Sanie said, noting that the uterus often feels enlarged.
If fibroids are suspected, then the next step usually involves imaging, commonly with a pelvic ultrasound ― though tests including sonohysterography, hysteroscopy, hysterosalpingography and laparoscopy can also offer information.
'Some patients come in reporting symptoms, but for others it might be diagnosed during a routine exam,' As-Sanie noted. 'They may have had no clinical symptoms. Or if they're having trouble becoming pregnant, fibroids may be discovered as they look into their fertility problems.'
What is the treatment for fibroids?
If you're diagnosed with uterine fibroids, the next steps depend on your symptoms. You might not need treatment if your fibroids are small and aren't causing symptoms or if you're nearing menopause.
'If someone's not having symptoms, we typically just survey them over time,' As-Sanie said. 'They should get regular checkups to monitor for development of symptoms if they're not having them. Often we'll get repeat imaging every year or couple years to monitor for fibroid growth.'
For patients with symptoms, it's important to examine the symptoms they're having and what their goals are.
'With heavy bleeding, this can often be managed with medications ― like hormonal birth control pills, progestin-only birth control methods, other pills and injections,' As-Sanie said.
Although those methods are effective for many patients, they don't work for others. And over time other interventions might become necessary.
Myomectomy is the surgical removal of fibroids, and uterine artery embolization (sometimes called uterine fibroid embolization) is a less-invasive procedure that involves injecting tiny particles into the blood vessels to stop blood flow to the fibroids and cause them to shrink.
'There are also different types of ablations where you can use forms of energy to basically burn them away or make them smaller,' Valbrun said. She added that the recovery process after fibroid-related procedures can be lengthy, noting that it took her about eight weeks to recovery from her myomectomy.
Some fibroids are too small to be removed, and even after you've had fibroids removed or shrunk, there's always a possibility of regrowth or new ones appearing. And some patients have so many fibroids that it wouldn't be feasible to remove all of them. As a result, the only total cure is hysterectomy.
'The choice of what treatment is appropriate in patients very much depends on both a combination of things, like their age and desire to preserve fertility, as well as fibroid size and location,' As-Sanie said. 'Hysterectomy is generally considered a last resort when other things haven't worked, but it is considered curative and it's quite common in the U.S. And uterine fibroids and abnormal bleeding are the most common non-cancerous reasons that women have hysterectomies.'
What should you do if you suspect fibroids?
'Any symptoms of heavy bleeding and/or pelvic pain that are bothersome enough that they're interfering with your quality of life warrant evaluation,' As-Sanie said. 'There's no amount of bleeding or pain we would say is automatically 'normal.' If you're not able to work as effectively or enjoy your life, that is by definition considered abnormal and deserves evaluation.'
Fibroids are relatively common, but they're also just one of many potential causes for increased levels of pain and bleeding. It's important to see a medical professional to help figure out what might be at the root of your problems and determine the best course of treatment.
Many experience pregnancy complications or infertility related to fibroids, but medical interventions can help. So if you're hoping to give birth someday, know that fibroids don't necessarily prevent that.
'For many women who have fibroids but no symptoms, we don't automatically recommend treatment in order to get pregnant or have a successful or healthy pregnancy,' As-Sanie said. 'The relationship between fibroids and fertility and pregnancy is complicated, but there are many women who have fibroids ― even fibroids that cause symptoms ― that can become pregnant and carry a healthy pregnancy without needing intervention.'
And remember that there's nothing shameful about fibroids or any other gynecological issue.
'Patients often feel like it's embarrassing, and their families ― or even physicians they've seen ― have dismissed or minimized their pain as being a normal part of a woman's experience,' As-Sanie said. 'This is unfair and unhelpful to women.'
She urged patients and medical providers to help break down the stigma around menstrual disorders.
'We need to improve awareness and diagnosis, as well as reduce the bias and stigma by talking about pain and bleeding so that young girls and women don't dismiss it as normal or think it's too shameful to talk about,' As-Sanie emphasized. 'That way they can get earlier diagnoses and treatments.'
What else should people know about uterine fibroids?
Valbrun is dedicated to raising awareness and clearing up misconceptions about uterine fibroids. In 2014, she launched The White Dress Project to spread the word, increase funding for medical research and offer support to other people who are living with fibroids.
'I want to make people feel like they are not alone,' she said. 'And I wanted the support for myself because I never saw any organized walks or runs or people asking me to buy a T-shirt about fibroid awareness. It feels very lonely to feel like you're the only one on the bathroom floor in the fetal position. You're the only one canceling on your girlfriends, the only one not spending the night at a guy's house even though you want to.'
The name stems from her desire to reclaim the color white as a symbol of hope and empower herself and others to feel comfortable wearing white ― or to do it anyway in an act of rebellion against the limits fibroids can impose. The White Dress Project hosts community events, offers educational resources, supports research and advocates for policy in support of fibroid awareness.
Michigan state Rep. Kyra Harris Bolden (D) has also gotten involved in advocacy after being diagnosed with fibroids in 2020 and undergoing a myomectomy.
'It took me seven weeks to get back to what I felt was 100%, but ever since then, I've been on this quest to just bring more awareness to fibroids,' she told HuffPost. 'After I shared my story on the House floor during Uterine Fibroid Awareness Month, I got an outpouring of messages from women sharing their fibroid experience and how horrific it had been.'
Bolden has also partnered with organizations to spread awareness, worked on legislation and even helped get funding allocated for fibroid research in the Michigan state budget.
'This condition affects so many women but isn't widely talked about,' she said. 'If I had known it was so common, I probably wouldn't have waited until my condition got so bad to seek treatment and could've had a less invasive surgery.'
Valbrun also wants to spread the word about the different treatment options for fibroids.
'A lot of times, hysterectomy is the only option offered for women to deal with fibroids,' she said. 'Black women are more likely to be offered hysterectomy. I was told to have a hysterectomy when I was 26 and use a surrogate if I wanted children, and it was really disheartening. Fortunately, I found another doctor who told me about my other options.'
Of course, many patients are great candidates for a hysterectomy, especially if they are done having children or don't want to give birth, but Valbrun wants to make sure people feel informed and empowered about this decision rather than pressured.
'Remember that you are powerful and have a say,' she said. 'Nobody knows your body like you do.'
Related...
9 Red Flags You May Have PCOS, According To Experts
Are 'Dropsies' During Your Period A Real Thing?
4 Signs Your Period Pain Isn't Normal
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Michael Madsen cremated, more details about actor's death emerge
Michael Madsen cremated, more details about actor's death emerge

Yahoo

time21 minutes ago

  • Yahoo

Michael Madsen cremated, more details about actor's death emerge

Actor Michael Madsen was cremated this week following his death earlier his month, about which more details are now emerging. A number of conditions, including cardiomyopathy — which makes it more difficult for the heart to pump blood throughout the body — along with coronary artery disease and chronic alcoholism all contributed to the cardiac arrest that ultimately killed the 67-year-old 'Kill Bill' star, according to a death certificate issued by Los Angeles County Medical Examiner and obtained by TMZ on Thursday. Thromboembolic disease, when vessels or arteries are blocked by blood clots, was also identified as a significant contributing factor. The death certificate shows that Madsen, who'd reportedly gotten sober in recent months, died less than two months after undergoing coronary angiography, which uses X-rays to look at the heart's blood vessels, per Mayo Clinic. Madsen's manager Ron Smith previously confirmed to NBCLA that Madsen died at his Malibu, California, home on July 3 from cardiac arrest. Days later, Madsen's cardiologist told the outlet that heart disease and alcoholism would be listed as contributing factors to his heart failure. Sister and fellow actor, Oscar nominee Virginia Madsen, remembered her big brother as 'half legend, half lullaby' — 'etched in contradiction, tempered by love that left its mark.' Madsen is survived by four children, including his son Christian, who is also an actor. He was predeceased by one of his sons, Hudson, who died by suicide in 2022.

Rare 'flesh-eating' bacteria claims 4 lives in Florida: What to know
Rare 'flesh-eating' bacteria claims 4 lives in Florida: What to know

Yahoo

time21 minutes ago

  • Yahoo

Rare 'flesh-eating' bacteria claims 4 lives in Florida: What to know

Florida health officials reported that four people died and over a half dozen others were made sick this year by a rare "flesh-eating" bacteria. Vibrio vulnificus, which is found in saltwater, brackish water and inside contaminated raw or undercooked seafood, led to four deaths in four counties across the state and made at least seven people ill, the state's Department of Health announced on July 11. Infection from the bacteria is rare, with an average of 150 to 200 cases reported each year to the Center for Disease Control and Prevention (CDC). Cases are most often reported in the Gulf Coast states, though research has shown it migrating north as climate change fuels warmer oceans. Most healthy people exposed to the bacteria experience only mild symptoms. For some, however, the bacteria can be deadly – especially if it enters the bloodstream or kills flesh around an open wound. About one in five people die from the infection, according to the CDC, sometimes within one to two days of becoming ill. Others may require surgery or even amputation after their exposure. Here's what to know about Vibrio vulnificus: Where is Vibrio vulnificus located? Vibrio are bacteria that naturally live in coastal waters year-round. Vibrio vulnificus requires saltwater to live and spread, though it can thrive in brackish water, where a stream or river meets seawater. Most infections occur when people swallow contaminated water or get it in an open wound. Another source of infection is contaminated raw or undercooked seafood, especially shellfish such as oysters. In Florida, which leads the nation in Vibrio vulnificus infections, spikes in cases and deaths coincide with major hurricanes, when seawater is carried on shore, triggering flooding and dumping seawater into freshwater sources. Between 2016 to 2024, an average of 48 Vibrio vulnificus cases and about 11 deaths were reported annually in Florida. In 2022, when Hurricane Ian battered communities along the southwest coast, there were 74 reported cases and 17 deaths. Last year, the state recorded 82 cases and 19 deaths – a surge health officials tied to a pair of damaging hurricanes, Helene and Milton. Why is it called a 'flesh-eating bacteria'? Vibrio vulnificus kills, but does not eat tissue. The bacteria cannot penetrate unharmed skin, but can enter through an existing break. If the bacteria enters the body through a cut, scrape or wound, it can cause necrotizing fasciitis, and the flesh around the infection site could die. Those infected through wounds may require major surgery or limb amputations, according to the CDC. What are the symptoms of Vibrio vulnificus? Common symptoms of Vibrio vulnificus infection include diarrhea, stomach cramps, nausea, vomiting and fever, according to the CDC. When open wounds are exposed to contaminated salt or brackish water, Vibrio vulnificus can cause discoloration, swelling, skin breakdown and ulcers. The bacteria can also invade the bloodstream and threaten severe and life-threatening illnesses such as septic shock, especially for those with pre-existing conditions. "Vibrio vulnificus bloodstream infections are fatal about 50 percent of the time," according to the Florida Department of Health. How to avoid Vibrio vulnificus Below are some tips to avoid Vibrio vulnificus, according to the Florida Department of Health and the CDC. Stay out of saltwater and brackish water if you have an open wound or cut. If you get a cut while you are in the water, leave the water immediately. If your open wounds and cuts could come in contact with salt water, brackish water or raw or undercooked seafood, cover them with a waterproof bandage. Cook shellfish (oysters, clams, mussels) thoroughly. Avoid cross-contamination of cooked seafood and other foods with raw seafood and juices from raw seafood. Always wash your hands with soap and water after handling raw shellfish. Seek medical attention right away for infected wounds. Contributing: Natalie Neysa Alund, Thao Nguyen, Gabe Hauari and Mike Snider, USA TODAY; C.A. Bridges, USA TODAY Network - Florida This article originally appeared on USA TODAY: Rare 'flesh-eating' bacteria kills 4 people in Florida: What to know Solve the daily Crossword

Rapid Review: Endometrial Cancer
Rapid Review: Endometrial Cancer

Medscape

time23 minutes ago

  • Medscape

Rapid Review: Endometrial Cancer

In endometrial cancer, the majority of cases are diagnosed at an early stage, largely due to the hallmark symptom of postmenopausal bleeding. Despite relatively favorable survival rates when caught early — with a 5-year relative survival rate of approximately 95% for localized disease — disparities remain in detection, treatment access, and mortality. ctDNA testing has shown strong value as a noninvasive and highly sensitive method for detecting recurrence in endometrial cancer. ctDNA detects tumor-specific mutations in the bloodstream and is being actively evaluated to track cancer progression, detect early-stage cancers, and monitor therapeutic responses. ctDNA's role for detecting hormone receptor status and tumor histology has not been established for endometrial cancer, and it appears to not be correlated with myometrial invasion depth. Learn more about the presentation of endometrial cancer. In the past year, evidence has emerged which demonstrates that GLP-1 receptor agonists — medications originally approved for diabetes and obesity — reduce the risk for obesity-related cancers. A major research effort found that these drugs decreased cancer incidence, and further research found GLP-1 receptor agonists to be comparable to bariatric surgery for obesity-related cancer prevention. GLP-1 therapies now offer a less-invasive alternative to bariatric surgery. Research is ongoing to evaluate the use of GLP-1 medications as a potential therapeutic strategy for endometrial cancer. The other classes have not been shown to reduce risk or are not used in endometrial cancer management. Learn more about the differential diagnosis for endometrial cancer. Recent advances in molecular and genomic profiling have significantly refined the precision with which therapies can be selected for patients with endometrial cancer. These tools enable clinicians to pinpoint genetic and molecular characteristics that dictate tumor behavior and response to treatment, improving personalized treatment strategies and overall survival outcomes. Rather than uniformly applying treatments, clinicians have the ability to tailor therapies based on individual molecular profiles. Adjuvant therapy may still be warranted depending on the risk associated with the molecular/genomic subtypes identified, and best practice histopathology evaluation is still needed even when advanced profiling is done. Further research continues to expand the depth and breadth of genomic profiling, making it a crucial element of modern oncology practice. Learn more about the workup for endometrial cancer. The TCGA molecular classification divides endometrial cancers into four biologically distinct subtypes: POLE-ultramutated, MSI-H, copy number-low (endometrioid), and copy number-high (serous-like). These molecular profiles provide prognostic insights and increasingly guide therapeutic strategies beyond traditional histology and staging. For example, POLE-mutated tumors, despite high mutation burdens, have excellent outcomes and may not require aggressive adjuvant therapy. In contrast, copy number-high tumors are associated with poor prognosis and may benefit from more intensive treatment and HER2-targeted therapies. This classification is part of a shift toward personalized medicine in gynecologic oncology. Learn more about guidelines for endometrial cancer. Compared to traditional open surgery, MIS dramatically shortens hospital stays, decreases blood loss, and has fewer overall complications, although it does lengthen operation time. Furthermore, minimally invasive approaches maintain oncologic outcomes comparable to those of traditional open surgery, providing reassurance regarding their safety and efficacy. Because endometrial cancer patients often have obesity, MIS has the potential to reduce the risk for postoperative wound complications. It also is likely to decrease other postoperative morbidities by supporting faster recovery and earlier resumption of normal daily activities. Additionally, lymph node assessment may still be needed after MIS. Learn more about risk assessment in patients with endometrial cancer.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store